Gyre Therapeutics (GYRE) Amortizatization of Intangibles (2010 - 2015)
Gyre Therapeutics (GYRE) posted quarterly Amortizatization of Intangibles of $63000.0 for Q2 2015, down 72.12% year-over-year from $226000.0 in Q2 2014, and down 35.05% quarter-over-quarter from $97000.0 in Q1 2015.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Amortizatization of Intangibles for 6 consecutive years, with $63000.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Amortizatization of Intangibles fell 72.12% year-over-year to $63000.0; the TTM figure through Jun 2015 stood at $484000.0 (down 41.62% YoY), while the FY2014 annual figure was $775000.0, down 14.65% from the prior year.
- Amortizatization of Intangibles fell to $63000.0 in Q2 2015 per GYRE's latest filing, from $97000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $335000.0 in Q3 2011 and bottomed at $63000.0 in Q2 2015.
- Historically, Amortizatization of Intangibles has averaged $205055.6 across 5 years, with a median of $225500.0 in 2013.
- Annual changes were most pronounced in 2011 — Amortizatization of Intangibles surged 125.0% — and 2015, when it slumped 72.12%.
- Gyre Therapeutics' Amortizatization of Intangibles stood at $270000.0 in 2011, then fell by 23.33% to $207000.0 in 2012, then advanced by 10.14% to $228000.0 in 2013, then slumped by 37.72% to $142000.0 in 2014, then tumbled by 55.63% to $63000.0 in 2015.
- Business Quant data shows GYRE's Amortizatization of Intangibles at $63000.0 in Q2 2015, $97000.0 in Q1 2015, and $142000.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 63,000.00 |
| Mar 31, 2015 | 97,000.00 |
| Dec 31, 2014 | 142,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Jun 30, 2014 | 226,000.00 |
| Mar 31, 2014 | 225,000.00 |
| Dec 31, 2013 | 228,000.00 |
| Sep 30, 2013 | 150,000.00 |
| Jun 30, 2013 | 304,000.00 |
| Mar 31, 2013 | 226,000.00 |
| Dec 31, 2012 | 207,000.00 |
| Sep 30, 2012 | 253,000.00 |
| Jun 30, 2012 | 238,000.00 |
| Mar 31, 2012 | 239,000.00 |
| Dec 31, 2011 | 270,000.00 |
| Sep 30, 2011 | 335,000.00 |
| Jun 30, 2011 | 169,000.00 |
| Mar 31, 2011 | 137,000.00 |
| Dec 31, 2010 | 120,000.00 |
| Sep 30, 2010 | 181,000.00 |